Dyax Corp. and FivePrime Therapeutics, Inc. Enter Into Research Agreement for Discovery of Therapeutic Antibodies

Published: Apr 27, 2011

CAMBRIDGE, Mass. & SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Dyax Corp. (NASDAQ:DYAX) and Five Prime Therapeutics, Inc. (FivePrime) announced today that they have entered into an antibody funded research agreement for the discovery of therapeutic antibodies.

Back to news